Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Tara Sanft Explores VEGF as a Link Between Diabetes and Cancer

      June 16, 2016
      By Tara Sanft, MD
      Video

      Tara Sanft, MD, Yale Cancer Center, discusses VEGF as a possible link between diabetes and cancer.

      Tara Sanft, MD, Yale Cancer Center, discusses VEGF as a possible link between diabetes and cancer.

      VEGF promotes blood vessel formation known to play a role in breast cancer tumor formation. It is also prominent in conditions such as diabetes, which also has a link to cancer. Sanft led a study that measured VEGF levels in patients before and after implementing lifestyle changes (including diet and exercise) and found that there was a significant decrease in the growth factor after the change.

      Sanft hopes to use these results, as well as future studies on a larger scale, to find out the mechanisms as to why obesity is linked to the development of breast cancer.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      2 experts are featured in this series.
      2 experts are featured in this series.
      Related Content

      Graphic depicting a nurse with a cell strucutre behind. Graphic by Gwendolyn Salas, MJH Life Sciences, with AI

      Structure to Safety: A Nurse's Guide to Safe ADC Care

      Ellen Rice Tichich, MFA, MSN, RN, NPD-BC
      September 12th 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      September 12th 2025
      Podcast

      Line illustration of a breast on a yellow background

      CDK4/6 Inhibitors: How to Tailor Treatment Choices by AEs

      Bridget Hoyt
      September 12th 2025
      Article

      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      September 12th 2025
      Podcast

      Icon of a breast with various clinicians using medical equipment

      Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events

      Bridget Hoyt
      September 12th 2025
      Article

      Image of a person with a breast tumor

      Making Breast Cancer Treatment Decisions After Endocrine Therapy

      Bridget Hoyt
      September 12th 2025
      Article
      Related Content

      Graphic depicting a nurse with a cell strucutre behind. Graphic by Gwendolyn Salas, MJH Life Sciences, with AI

      Structure to Safety: A Nurse's Guide to Safe ADC Care

      Ellen Rice Tichich, MFA, MSN, RN, NPD-BC
      September 12th 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      September 12th 2025
      Podcast

      Line illustration of a breast on a yellow background

      CDK4/6 Inhibitors: How to Tailor Treatment Choices by AEs

      Bridget Hoyt
      September 12th 2025
      Article

      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      September 12th 2025
      Podcast

      Icon of a breast with various clinicians using medical equipment

      Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events

      Bridget Hoyt
      September 12th 2025
      Article

      Image of a person with a breast tumor

      Making Breast Cancer Treatment Decisions After Endocrine Therapy

      Bridget Hoyt
      September 12th 2025
      Article

      Latest Conference Coverage

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

      Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

      Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.